Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Differential Peripheral Blood Glycoprotein Profiles in Symptomatic and Asymptomatic COVID-19

Chad Pickering, Bo Zhou, Gege Xu, Rachel Rice, Prasanna Ramachandran, Hector Huang, Tho D. Pham, Jeffrey M. Schapiro, Xin Cong, Saborni Chakraborty, Karlie Edwards, Srinivasa T. Reddy, Faheem Guirgis, Taia T. Wang, Daniel Serie, Klaus Lindpaintner
doi: https://doi.org/10.1101/2022.01.07.21267956
Chad Pickering
1InterVenn Biosciences, South San Francisco, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: cpickering@venn.bio
Bo Zhou
1InterVenn Biosciences, South San Francisco, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gege Xu
1InterVenn Biosciences, South San Francisco, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rachel Rice
1InterVenn Biosciences, South San Francisco, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Prasanna Ramachandran
1InterVenn Biosciences, South San Francisco, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hector Huang
1InterVenn Biosciences, South San Francisco, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tho D. Pham
4Blood Center, Palo Alto, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeffrey M. Schapiro
5TPMG Regional Reference Laboratory, Kaiser Permanente Northern California, Berkeley, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xin Cong
1InterVenn Biosciences, South San Francisco, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Saborni Chakraborty
3Department of Medicine, Division of Infectious Diseases, Stanford University, Stanford, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karlie Edwards
3Department of Medicine, Division of Infectious Diseases, Stanford University, Stanford, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Srinivasa T. Reddy
6University of California Los Angeles, Department of Molecular and Medical Pharmacology, Los Angeles, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Faheem Guirgis
2University of Florida, Jacksonville, FL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Taia T. Wang
3Department of Medicine, Division of Infectious Diseases, Stanford University, Stanford, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel Serie
1InterVenn Biosciences, South San Francisco, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Klaus Lindpaintner
1InterVenn Biosciences, South San Francisco, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Glycosylation is the most common form of post-translational modification of proteins, critically affecting their structure and function. Using liquid chromatography and mass spectrometry for high-resolution site-specific quantification of glycopeptides coupled with high-throughput artificial intelligence-powered data processing, we analyzed differential protein glyco-isoform distributions of 597 abundant serum glycopeptides and non-glycosylated peptides in 50 individuals who had been seriously ill with COVID-19 and in 22 individuals who had recovered after an asymptomatic course of COVID-19. As additional comparison reference phenotypes, we included 12 individuals with a history of infection with a common cold coronavirus, 16 patients with bacterial sepsis, and 15 healthy subjects without history of coronavirus exposure. We found statistically significant differences, at FDR<0.05, for normalized abundances of 374 of the 597 peptides and glycopeptides interrogated, between symptomatic and asymptomatic COVID-19 patients. Similar statistically significant differences were seen when comparing symptomatic COVID-19 patients to healthy controls (350 differentially abundant peptides and glycopeptides) and common cold coronavirus seropositive subjects (353 differentially abundant peptides and glycopeptides). Among healthy controls and sepsis patients, 326 peptides and glycopeptides were found to be differentially abundant, of which 277 overlapped with biomarkers that showed differential expression between symptomatic COVID-19 cases and healthy controls. Among symptomatic COVID-19 cases and sepsis patients, 101 glycopeptide and peptide biomarkers were found to be statistically significantly abundant. Using both supervised and unsupervised machine learning techniques, we found specific glycoprotein profiles to be strongly predictive of symptomatic COVID-19 infection. LASSO-regularized multivariable logistic regression and K-means clustering yielded accuracies of 100% in an independent test set and of 96% overall, respectively. Our findings are consistent with the interpretation that a majority of glycoprotein modifications observed which are shared among symptomatic COVID-19 and sepsis patients likely represent a generic consequence of a severe systemic immune and inflammatory state. However, there are glyco-isoform changes that are specific and particular to severe COVID-19 infection. These may be representative of either COVID-19-specific consequences or of susceptibility to or predisposition for a severe course of the disease. Our findings support the potential value of glycoproteomic biomarkers in the biomedical understanding, and, potentially, the clinical management of serious acute infectious conditions.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study was funded by InterVenn

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Use of the samples for this study was approved by the Institutional Review Board of Stanford University under Study Review Protocol no. 55718.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted January 08, 2022.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Differential Peripheral Blood Glycoprotein Profiles in Symptomatic and Asymptomatic COVID-19
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Differential Peripheral Blood Glycoprotein Profiles in Symptomatic and Asymptomatic COVID-19
Chad Pickering, Bo Zhou, Gege Xu, Rachel Rice, Prasanna Ramachandran, Hector Huang, Tho D. Pham, Jeffrey M. Schapiro, Xin Cong, Saborni Chakraborty, Karlie Edwards, Srinivasa T. Reddy, Faheem Guirgis, Taia T. Wang, Daniel Serie, Klaus Lindpaintner
medRxiv 2022.01.07.21267956; doi: https://doi.org/10.1101/2022.01.07.21267956
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Differential Peripheral Blood Glycoprotein Profiles in Symptomatic and Asymptomatic COVID-19
Chad Pickering, Bo Zhou, Gege Xu, Rachel Rice, Prasanna Ramachandran, Hector Huang, Tho D. Pham, Jeffrey M. Schapiro, Xin Cong, Saborni Chakraborty, Karlie Edwards, Srinivasa T. Reddy, Faheem Guirgis, Taia T. Wang, Daniel Serie, Klaus Lindpaintner
medRxiv 2022.01.07.21267956; doi: https://doi.org/10.1101/2022.01.07.21267956

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (280)
  • Allergy and Immunology (580)
  • Anesthesia (141)
  • Cardiovascular Medicine (1969)
  • Dentistry and Oral Medicine (253)
  • Dermatology (188)
  • Emergency Medicine (336)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (704)
  • Epidemiology (11130)
  • Forensic Medicine (8)
  • Gastroenterology (631)
  • Genetic and Genomic Medicine (3204)
  • Geriatric Medicine (310)
  • Health Economics (569)
  • Health Informatics (2054)
  • Health Policy (864)
  • Health Systems and Quality Improvement (793)
  • Hematology (311)
  • HIV/AIDS (686)
  • Infectious Diseases (except HIV/AIDS) (12750)
  • Intensive Care and Critical Care Medicine (708)
  • Medical Education (320)
  • Medical Ethics (92)
  • Nephrology (339)
  • Neurology (3005)
  • Nursing (167)
  • Nutrition (466)
  • Obstetrics and Gynecology (591)
  • Occupational and Environmental Health (614)
  • Oncology (1566)
  • Ophthalmology (478)
  • Orthopedics (189)
  • Otolaryngology (267)
  • Pain Medicine (204)
  • Palliative Medicine (57)
  • Pathology (404)
  • Pediatrics (916)
  • Pharmacology and Therapeutics (387)
  • Primary Care Research (357)
  • Psychiatry and Clinical Psychology (2811)
  • Public and Global Health (5622)
  • Radiology and Imaging (1104)
  • Rehabilitation Medicine and Physical Therapy (637)
  • Respiratory Medicine (765)
  • Rheumatology (342)
  • Sexual and Reproductive Health (316)
  • Sports Medicine (291)
  • Surgery (351)
  • Toxicology (48)
  • Transplantation (159)
  • Urology (133)